A little over a year ago, I posted my thoughts on GLP-1 agonist medications (that’s things like Ozempic, Wegovy, Mounjaro, and Zepbound). In all, I offered some serious criticisms and concerns of these medication. You can read my initial post by clicking here.
I want to return to the topic of GLP-1 medications today, because since that post my thinking on these medications has evolved. That’s not because I’ve changed my philosophy. I still have many of the concerns that I outlined in my initial post. However, science constantly makes new discoveries, and it’s a professional obligation of mine to keep an open mind and evaluate new pieces of data as they come in, constantly weighing the risks versus the benefits of various treatments.
The fact is that over the past year, a string of new studies have come out suggesting that there may be far more benefits to GLP-1 medications than were previously realized. I’ll briefly touch on just a few here:
